Raymond James Financial’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$163M Buy
1,345,548
+281,315
+26% +$33.1M 0.04% 368
2026
Q2
$108M Sell
1,064,233
-2,773
-0.3% -$287K 0.03% 533
2026
Q1
$104M Sell
1,067,006
-307,676
-22% -$31.6M 0.03% 503
2025
Q4
$147M Sell
1,374,682
-166,654
-11% -$19.3M 0.05% 368
2025
Q3
$196M Buy
1,541,336
+397,694
+35% +$47.3M 0.06% 277
2025
Q2
$140M Buy
1,143,642
+274,142
+32% +$31.3M 0.05% 354
2025
Q1
$88.1M Buy
869,500
+25,493
+3% +$2.49M 0.03% 475
2024
Q4
$77.9M Buy
+844,007
New +$82.9M 0.03% 514

Other funds holding EHC

Raymond James Financial's EHC Position: Q3 2026 in Review

Raymond James Financial increased its Encompass Health (EHC) stake by 26% in Q3 2026, buying an estimated $33.1M and bringing the position to 1,345,548 shares worth $163M. The position accounts for 0.04% of the portfolio, ranked #368.

Raymond James Financial first reported a position in EHC in Q4 2024 and has held it in 8 quarters since. The position peaked at $196M in Q3 2025. 628 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Raymond James Financial held 1,345,548 shares of Encompass Health worth $163M as of Q3 2026.
  • Raymond James Financial bought 281,315 Encompass Health shares in Q3 2026, an estimated $33.1M.
  • Encompass Health made up 0.04% of Raymond James Financial's portfolio in Q3 2026, its #368 holding.
  • Raymond James Financial first reported a position in Encompass Health in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Encompass Health position peaked at $196M in Q3 2025.
  • 628 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.